Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Bohlin Garen G sold 8,700 Collegium Pharmaceutical, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Bohlin Garen G (Director) sold 8,700 Collegium Pharmaceutical, Inc. shares at US$37.18 for US$323K, leaving 62,259 shares. Filed May 13, 2026 (Form 4).
- Sold
- 8,700 shares
- Price
- US$37.18
- Value
- US$323K
- Holding after
- 62,259 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Option exercise | 8,700 | US$16.49 | 70,959 | Direct |
| May 11, 2026 | Common Stock | Sale | 8,700 | US$37.18 | 62,259 | Direct |
Source
Related
- Collegium Pharmaceutical, Inc.
- Bohlin Garen G
- Collegium Pharmaceutical, Inc. shareholders
- Form 4 · Bohlin Garen G · May 18, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026